NEWMarkets
Spyre Therapeutics (SPYR) CEO Cameron Turtle Sells $1.3M in Shares
Published on 9/4/2026
AI Summary
Summarized by AI from the source belowCameron Turtle, CEO of Spyre Therapeutics (SPYR), sold $1.3 million worth of shares. This transaction marks a significant event as it involves a high-profile executive selling a substantial amount of stock in the company. Sales by executives can sometimes indicate insider sentiment about the company's future performance. Investors may view this event as a signal that could influence market perceptions of Spyre Therapeutics.
Get the free market brief
Top stories and analysis, summarized. No spam, unsubscribe anytime.
